PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24222N0244Chemotherapy compounding — Optum Pharmacy 801, Inc

Optum Pharmacy 801, Inc holds $4.1M across 82 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C24222A0007. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. PoP ended Nov 16, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

242-Network Contract Office 02 (36C242)
Awarding office
Optum Pharmacy 801, Inc
Recipient
Nov 16, 2022
PoP end
$822K
Obligated
$900K
Potential
325412
NAICS
6505
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number36C24222N0244
Also listed as36C242-22-N-0244
Also listed as36C24222A0007-36C24222N0244
Agency242-Network Contract Office 02 (36C242)
Awarding office242-Network Contract Office 02 (36C242)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentOptum Pharmacy 801, Inc
CAGE6ABG3
UEIK5MHR9JB9ND5
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36C24222A0007
Place of performancePHOENIX AZ
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
PoP startNov 17, 2021
PoP end (current)Nov 16, 2022
PoP end (w/ options)Nov 16, 2026
Obligated$822K
Current value$900K
Potential value$900K

CHEMOTHERAPY COMPOUNDING is a federal Unrestricted award for 242-Network Contract Office 02 (36C242) held by Optum Pharmacy 801, Inc. Estimated value $900K ($822K obligated). Current period of performance ends Nov 16, 2022 (potential Nov 16, 2026). Last award drew 1 bidder. Place of performance: PHOENIX AZ.

Recompete timing

Public
● Past PoP end (1414 days ago)

Current PoP ended Nov 16, 2022 (1414 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 36C24222N0244? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Optum Pharmacy 801, Inc — $4.1M obligated across 82 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$4.1M · 100% of firm total
Open full company profile →

Related awards

Same parent · incumbent
36C26126N0060
CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO, ADD ITEMS
$500K
Sep 30, 2026
36C25622F0023
HAZARDOUS STERILE COMPOUND
$487K
Sep 30, 2026
36C25623F0043
EO14042 HAZARDOUS STERILE COMPOUND - FUND OPTION YEAR ONE
$487K
Sep 30, 2026
36C26126N0050
ORDERING PERIOD 3 - CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING
$441K
Sep 30, 2026
36C25626F0036
ORDERING PERIOD 4 - STERILE COMPOUNDING
$100K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C24222N0244?

36C24222N0244 (Chemotherapy compounding) is a 242-Network Contract Office 02 (36C242) award with a potential value of $900K, currently held by Optum Pharmacy 801, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C242-22-N-0244?

36C242-22-N-0244 is the dashed form of PIID 36C24222N0244 (Chemotherapy compounding), held by Optum Pharmacy 801, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24222N0244?

242-Network Contract Office 02 (36C242) awarded 36C24222N0244 to Optum Pharmacy 801, Inc (potential $900K).

Who is the incumbent on 36C24222N0244?

Optum Pharmacy 801, Inc is the incumbent with $4.1M across 82 related awards in SCOUT’s public footprint. The current period of performance ends Nov 16, 2022.

When does Optum Pharmacy 801, Inc’s 36C24222N0244 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 16, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C24222N0244? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C24222N0244